title: Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetes.
abstract: BACKGROUND
  Insulin allergy is a rare complication of insulin use. Localized lipoatrophy is also known to occur following subcutaneous injections of insulin.
  
  
  METHODS
  A 53-year-old non-obese female patient with Type 2 diabetes displayed local allergic-type symptoms to all available insulin preparations. This was complicated by the development of severe lipoatrophy on her abdominal and thigh injection sites and subsequently resulted in suboptimal glycaemic control.
  
  
  CONCLUSIONS
  Whilst uncommon, insulin allergy and lipoatrophy can cause major problems in diabetic management. Potential pathophysiological mechanisms and a stepwise approach to management are discussed.
authors.affiliation: Department of Diabetes and Endocrinology, The Hillingdon Hospital, Uxbridge, UK. aniket.tavare@gmail.com
authors.forename: A N
authors.initials: AN
authors.lastname: Tavare
authors.forename: H J
authors.initials: HJ
authors.lastname: Doolittle
authors.forename: R
authors.initials: R
authors.lastname: Baburaj
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin